Immunotherapy in NMSC: Bringing the Data to Life

Program Overview

This activity features an interprofessional, multidisciplinary panel of experts offering privileged insights on immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). Uniquely, this evidence-based discussion is augmented by perspectives from a patient panelist sharing key aspects of their own treatment journey.

Credit Expired
0.5 CE Credit(s)
Expires: January 31, 2024

Target Audience

Medical oncology and dermatology clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Assess current clinical evidence for immunotherapy-based treatment of advanced nonmelanoma skin cancers (NMSC)
  • Integrate immunotherapy in the management of advanced CSCC and BCC

Activity Faculty

Nikhil I. Khushalani, MD (Chair)

Nikhil I. Khushalani, MD (Chair)

Vice Chair and Senior Member
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL

Gina Corsanico, ARNP

Gina Corsanico, ARNP

Moffitt Cancer Center
Tampa, FL

Anokhi Jambusaria, MD, MSCE

Anokhi Jambusaria, MD, MSCE

Associate Professor, Internal Medicine
Division of Dermatology
Dell Medical School
Austin, TX

Supporter Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Provider Statement

Provided by RMEI Medical Education, LLC

Disclosure of Financial Relationships

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. 


Gina Corsanico, ARPN, has no relevant financial relationship(s) with ineligible companies to disclose.

Anokhi Jambusaria, MD, MSCE, has relevant financial relationships with Regeneron (Advisor).

Nikhil I. Khushalani, MD, has relevant financial relationships with Array BioPharma, AstraZeneca, Bristol Myers Squibb, Castle Biosciences, Genzyme, Immunocore, Incyte Corporation, Instil Bio, Iovance Biotherapeutics, Jounce Therapeutics, Merck, Nektar Therapeutics, Novartis, Pfizer, Regeneron (Advisor/Consultant); Bristol Myers Squibb, Celgene, Nektar Therapeutics, Regeneron, Replimune Group, Inc. (Other: Steering Committee); Amgen, Bristol Myers Squibb, Celgene, GlaxoSmithKline, HUYA Bioscience International, Merck, Modulation Therapeutics, Novartis, Regeneron, Replimune Group, Inc. (Research Funding); Amarin Pharmaceuticals, Asensus Surgical, Bellicum Pharmaceuticals (Stockholder).

Patient participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies. 

Planners and Managers

RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.


Accreditation Statement 

In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation 

Physician Continuing Medical Education 
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education 
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour(s).


Method of Participation and Request for Credit

In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected]. 

Users must: 

  • Read the learning objectives and faculty disclosures 
  • Participate in the activity 
  • Complete the activity evaluation and attest to credit

There is no fee to participate. 



*The expense for this gift card is solely funded by RMEI Medical Education, LLC. 
No supporter funding was used for the expense of this gift card. 

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.   

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources